$PLX News

Protalix BioTherapeutics, Inc. Q2 2026 Earnings Call Summary

PLX: Elfabrio Estimates Up

Protalix BioTherapeutics Inc (PLX) (Q2 2026) Earnings Call Highlights: Net Income Surges to $3. ...

Protalix BioTherapeutics, Inc. (PLX) Q2 2026 Earnings Call Transcript

Protalix BioTherapeutics Reports Second Quarter 2026 Financial and Business Results

Protalix BioTherapeutics Q2 EPS $0.05 Misses $0.12 Estimate, Sales $19.896M Beat $12.931M Estimate

Protalix BioTherapeutics to Announce Second Quarter 2026 Financial Results and Business Update on August 12, 2026

PLX: Chiesi Milestone Received

Protalix BioTherapeutics Inc (PLX) Q1 2026 Earnings Call Highlights: Strong Financial Position ...

Transcript: Protalix BioTherapeutics Q1 2026 Earnings Conference Call

Protalix BioTherapeutics, Inc. (PLX) Q1 2026 Earnings Call Transcript

Protalix BioTherapeutics Reports First Quarter 2026 Financial and Business Results

CORRECTION: Protalix BioTherapeutics Q1 EPS $0.22 Beats $0.06 Estimate, Sales $33.750M Beat $11.468M Estimate

Transcript: Protalix BioTherapeutics Q1 2026 Earnings Conference Call

Protalix BioTherapeutics to Announce First Quarter 2026 Financial Results and Business Update on May 13, 2026

Protalix Revenue Miss Overshadowed By Milestone-Backed 2026 Guidance

HC Wainwright & Co. Reiterates Buy on Protalix BioTherapeutics, Maintains $12 Price Target

Protalix BioTherapeutics Inc (PLX) Q4 2025 Earnings Call Highlights: Strategic Advances and ...

PLX: 2025 Full Year Results

Protalix BioTherapeutics advances Fabry disease and gout programs during 2025